OKT3 induction in 100 consecutive pancreas transplants

Transplant Proc. 1994 Apr;26(2):546-7.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 1 / surgery
  • Flow Cytometry
  • Follow-Up Studies
  • Graft Survival*
  • Humans
  • Immunosuppression Therapy / methods
  • Kidney Transplantation / immunology*
  • Muromonab-CD3 / therapeutic use*
  • Pancreas Transplantation / immunology*
  • Pancreas Transplantation / mortality
  • Risk Factors
  • Survival Rate
  • T-Lymphocyte Subsets / immunology
  • Time Factors

Substances

  • Muromonab-CD3